Legal precedent in Medicaid gender-affirming care ruling may impact broader drug coverage

Legal experts warn that the judicial reasoning used to restrict Medicaid coverage for gender-affirming care could establish a precedent for limiting coverage of other pharmaceutical treatments. The potential for this theory to be applied to broader drug classes remains uncertain but poses a significant risk to existing Medicaid coverage frameworks.